We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+2.48%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.39B
AUM Growth
-$215M
Cap. Flow
-$223M
Cap. Flow %
-16.08%
Top 10 Hldgs %
33.89%
Holding
326
New
35
Increased
50
Reduced
103
Closed
39

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$19M
2
WY icon
Weyerhaeuser
WY
+$17.1M
3
HBI
Hanesbrands
HBI
+$17.1M
4
VMC icon
Vulcan Materials
VMC
+$15.4M
5
CMCSA icon
Comcast
CMCSA
+$13.8M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$35.8M
2
JAH
JARDEN CORPORATION
JAH
+$35.4M
3
DD icon
DuPont de Nemours
DD
+$33.8M
4
PRU icon
Prudential Financial
PRU
+$30.2M
5
HLT icon
Hilton Worldwide
HLT
+$19.4M

Sector Composition

Rank Sector Weight
1 Industrials 18.75%
2 Communication Services 12.97%
3 Consumer Discretionary 12.04%
4 Healthcare 8.66%
5 Materials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
51
IBM
IBM
$209B
$1.77M 0.13%
12,244
-60,782
-83% -$7.76M
CHKP icon
52
Check Point Software Technologies
CHKP
$13.1B
$1.75M 0.13%
20,015
-1,175
-6% -$94.5K
B
53
Barrick Mining
B
$63.2B
$1.64M 0.12%
120,500
+10,500
+10% +$122K
UN
54
DELISTED
Unilever NV New York Registry Shares
UN
$1.56M 0.11%
35,000
– –
SYK icon
55
Stryker
SYK
$133B
$1.37M 0.1%
12,750
+9,050
+245% +$892K
NVO
56
Novo Nordisk
NVO
$228B
$1.35M 0.1%
50,000
– –
TMO icon
57
Thermo Fisher Scientific
TMO
$214B
$1.33M 0.1%
+9,375
New +$1.26M
TSM icon
58
TSMC
TSM
$2.09T
$1.31M 0.09%
50,053
– –
ALV icon
59
Autoliv
ALV
$9.09B
$1.3M 0.09%
15,268
-3,470
-19% -$275K
MSFT icon
60
Microsoft
MSFT
$3.35T
$1.3M 0.09%
23,598
+12,000
+103% +$629K
GLD icon
61
SPDR Gold Trust
GLD
$133B
$1.3M 0.09%
+11,016
New +$1.25M
BUD icon
62
AB InBev
BUD
$166B
$1.26M 0.09%
10,125
– –
MMM icon
63
3M
MMM
$90.8B
$1.23M 0.09%
8,794
+658
+8% +$84.5K
CNQ icon
64
Canadian Natural Resources
CNQ
$98.6B
$1.11M 0.08%
84,810
+10,342
+14% +$110K
NVS icon
65
Novartis
NVS
$301B
$1.1M 0.08%
16,963
– –
TEVA icon
66
Teva Pharmaceuticals
TEVA
$41.2B
$1.09M 0.08%
20,400
+400
+2% +$23.5K
DEO icon
67
Diageo
DEO
$49.5B
$1.08M 0.08%
10,000
– –
TM icon
68
Toyota
TM
$227B
$1.06M 0.08%
10,000
– –
SPY icon
69
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$1.05M 0.08%
5,108
+1,924
+60% +$375K
GSK icon
70
GSK
GSK
$104B
$1.02M 0.07%
20,131
+131
+0.7% +$6.53K
TTM
71
DELISTED
Tata Motors Limited
TTM
$1.02M 0.07%
35,000
– –
SNN icon
72
Smith & Nephew
SNN
$13.6B
$1M 0.07%
30,000
– –
RDY icon
73
Dr. Reddy's Laboratories
RDY
$9.85B
$994K 0.07%
110,000
-20,000
-15% -$179K
VOD icon
74
Vodafone
VOD
$37.2B
$992K 0.07%
30,954
+20,000
+183% +$623K
RDS.A
75
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$988K 0.07%
20,400
– –
1 2
3
4 5

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q1 2016 Portfolio in Review

As of Q1 2016, R.H. Bluestein & Co held 326 positions worth $1.39B, down 13% from $1.6B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

R.H. Bluestein & Co withdrew a net $223M in Q1 2016, closing 39 positions and reducing 103 holdings. Its most notable exit was JARDEN CORPORATION, an estimated $35.4M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Communication Services and Consumer Discretionary.

Against the trend, R.H. Bluestein & Co opened a new position in Devon Energy worth $21.4M.

  • R.H. Bluestein & Co's largest Q1 2016 buy was Devon Energy: 779,671 shares worth $21.4M.
  • R.H. Bluestein & Co added most to Weyerhaeuser in Q1 2016, an estimated $17.1M increase.
  • R.H. Bluestein & Co's biggest Q1 2016 reduction was Allergan plc, cutting an estimated $35.8M.
  • R.H. Bluestein & Co fully exited JARDEN CORPORATION in Q1 2016, selling an estimated $35.4M.
  • R.H. Bluestein & Co's ten largest holdings make up 34% of its $1.39B portfolio in Q1 2016.
  • R.H. Bluestein & Co opened 35 new positions and closed 39 in Q1 2016.
  • R.H. Bluestein & Co's portfolio value fell 13% quarter-over-quarter to $1.39B.

Based on R.H. Bluestein & Co's 13F filing for Q1 2016, filed 12 May 2016.